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Available online 9 November 2010AbstractThis work was conducted to identify virulence biomarkers for Paracoccidioides brasiliensis (Pb), the fungus responsible for Para-
coccidioidomycosis (PCM), a systemic disease endemic in Latin America. Measurement of mortality showed that all B10.A mice were killed
after 250 days by the virulent Pb18 isolate while only one of the mice that received the attenuated counterpart died. Also, number of lung CFUs
from virulent Pb18 inoculated mice were much higher when these isolates were compared. Phage display methodology allowed selection of
three phages that specifically bound to virulent Pb18. Variability of p04 phage binding to different Pb isolates were examples of variability of
expression by the fungus of its binding molecule, strongly suggesting p04 as a biomarker of virulence. In vitro, its derived peptide pep04 killed
only virulent fungi, and confocal microscopy showed that it was internalized only by the virulent isolate. Pep04 blocked establishment of Pb
infection in mice and virulent Pb18 pre-incubated with p04 showed significantly inhibited lung infection. Furthermore, infected mice treated
with p04 showed highly significant reduction in lung CFUs. These findings firmly establish p04 as a biomarker of Pb virulence. Therefore, after
proper peptide engineering, p04 may become a useful adjuvant for the distressing treatment of PCM.
 2010 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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Paracoccidioides brasiliensis is the agent of Para-
coccidioidomycosis (PCM) [1,2], a systemic granulomatous
mycosis restricted to SouthAmerican countries [3,4]. The disease
develops following inhalation of infectious propagules which
transform into pathogenic yeasts within the pulmonary alveolar
epithelium [2,5]. The clinical forms of PCM range from asymp-
tomatic patients to those that present with highmortality rates [2].
The spectrum of the disease depends on factors associated
with both the host immune response and characteristics of the* Corresponding author. Rua Botucatu 862, 4 andar. Sa˜o Paulo, SP 04023-
901, Brazil. Tel.: þ55 11 5549 6073; fax: þ55 11 55723328.
E-mail address: jdlopes@unifesp.br (J.D. Lopes).
1286-4579/$ - see front matter  2010 Institut Pasteur. Published by Elsevier Ma
doi:10.1016/j.micinf.2010.10.019infecting agent, mainly virulence [6,7]. The number of well
defined virulence factors for dimorphic fungal pathogens is
relatively small [8]. Several molecules were reported to be
involved in the pathogenicity of the fungus [9e14]. However,
they were found in all isolates studied, and did not discrimi-
nate either phenotypical differences or isolates that could be
correlated with the severity of the disease.
The characterization of molecules associated with pathoge-
nicity will enhance our understanding of the hosteparasite
relationship, lead to better evaluation of prognosis, and may be
useful in the development of new therapeutic agents. One of the
techniques used for this purpose is phage display, a technology
which has already facilitated the identification of diseasemarkers
and has driven drug design based on ligand directed targeting
[15]. Using phage display, we identified three different peptide-
displaying phages that bound to the surface of the high-virulent,sson SAS. All rights reserved.
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synthetic peptide from one of the phages (pep04) exhibited
fungicidal activity in vitro against P. brasiliensis as demonstrated
by inhibition of colony forming units (CFUs). Furthermore, the
corresponding phage, p04, prevented the in vivo lung coloniza-
tion by the fungus as well as its dissemination to other organs.
2. Material and Methods2.1. AnimalsSix-week-old male B10.A mice, bred under specific path-
ogen-free conditions at the animal facilities of the Federal
University of Sa˜o Paulo, Brazil, were used. All procedures and
experiments were performed according to the regulations of the
institutional Ethical Committee for animal experimentation,
Federal University of Sa˜o Paulo, Brazil, by which the study was
approved (CEP 0522/04, 25/03/2004). The animals were
handled according toNational Institutes ofHealtheUSA (NIH)
guide for care and use of laboratory animals (http://oacu.od.nih.
gov/ARAC/index.htm).2.2. Fungi and growthSix different P. brasiliensis isolates were used. Pb18, after
more than 5 years in culture, was demonstrably non-virulent. Two
isolates (T4B17 and T10B1) were originally obtained from
armadillos [16,17]. The virulence of T10B1 and T4B17 isolates
were assumed as described [17], high and intermediate virulence,
respectively. Mg16 was isolated from a single dental alveolus
lesion of a patient from the Laboratory of Medical Mycology,
State University of Maringa´, Brazil. This restricted type of
infection, with no open disease or dissemination, allows for the
assumption that it was a simple infectionwith very low virulence.
Pb339, a very well known isolate, was obtained from our
department fungal culture collection. To restore the Pb18 viru-
lence for the purpose of comparison to the attenuated Pb18 strain,
the strain was only used after serial passages in mice, the animal
model used throughout for experimental analysis as well as for
reestablishing lost virulence. This concept of attenuation or
loosing virulence by long termcultures came fromBrummer et al.
(1990) and Kashino et al. (1990) [18,19]. The attenuated Pb18
isolate had been previously maintained in culture in vitro for 5e6
years. All isolates were sub-cultivated weekly in semisolid Fava-
Netto’s medium [20] at 36 C and used on the 5th day of culture.2.3. Pathogenicity and virulence of P. brasiliensis
isolatesGroups of 6 mice of the B10.A strain were used to evaluate
mortality, number of CFUs, and histology. Briefly, the fungal
viability of five day cultures (generally over 90%)was verified by
trypan blue exclusion in a Neubauer chamber. Groups of mice
(6e8weeks old)were infected i.p. with 1 106 viable yeast cells
in 50ml of phosphate-buffered saline (PBS).Mortality of themice
was recorded for 250 days after intra-tracheal (i.t.) infection [21].
The number of viable microorganisms in the lungs, liver, andspleen from experimental and control mice were determined by
counting CFUs. Animals from each group were sacrificed at
different time intervals after infection and the number of viable
organisms in the organswere estimated as described [22]. Briefly,
the number of CFU was recovered in supplemented BHI plates.
The weighed organs of each mouse were macerated in 5 ml of
PBS, and 100 ml was plated in supplemented BHI. CFU for each
organ of individual mice was counted until no further growth
could be detected. The results were presented as log 10 of the
average value  standard error. For histopathological analysis,
the lung, spleen, and liver from each mouse were removed, fixed
in 10% formalin, and embedded in paraffin. Five-micrometer
sections were stained with hematoxylineeosin (H&E) and
examined microscopically.2.4. Biopanning and rapid analysis of selective
interactive ligands (BRASIL)The phage display library was screened for virulent isolate of
P. brasiliensis (Pb18) binding ligands by the BRASIL method
[23]. The library used in the present study contained the insert
CX7C (C, cysteine; X, any amino acid residue) [15]. Yeasts of
attenuated P. brasiliensis isolates suspended in PBS-BSA 1%
(w/v)were incubatedwith 109 transducing units (TU) of the phage
library. After 4 h the suspension was transferred to the top of
a nonmiscible organic lower phase with an intermediate specific
density solution and centrifuged (12,000 RPM, 15 min, 25 C)
[23]. The upper aqueous phase, containing phages that were
unbound to the attenuated isolate, was incubated with yeasts of
virulent P. brasiliensis, as described above. Following centrifu-
gation, yeasts of virulent Pb18entered the lower organic phase and
settled at the bottom of the tube, carrying only specifically bound
phages. The pellet was then transferred to another clean tube as
described [23]. Phages bound to virulent P. brasiliensis isolate
yeasts were rescued by infection of log-phase Escherichia coli
K91kan [24]. The next day, amplified phages were separated from
bacteria by polyethylene-glycol-NaCl precipitation and used for
subsequent selection rounds (109TU) to further enrich phages
binding specifically to yeasts of virulentP. brasiliensis. After three
complete rounds of selection, the DNA corresponding to peptide
inserts of randomly picked phage clones were sequenced
(approximately two hundred). Enriched peptide sequences were
analyzed by Clustal W, [EMBL in Heidelberg, Germany ([http://
www.ebi.ac.uk/Tools/clustalw2/index.html] Version 2) sequence
alignment. To measure phage binding, the insert-less phage (fd-
tet) was used as control [25]. Virulent or attenuated isolates of
P. brasiliensiswere co-incubatedwith selected peptide-displaying
or control phages. The binding to P. brasiliensis isolates was
quantified relative to fd-tet. In parallel, four isolatesP. brasiliensis
(T4B17, T10B1, Pb339, Mg16) were co-incubated with selected
peptide-displaying or control phages and similarly quantified.2.5. Peptide synthesis and purification for screeningPeptide synthesis and purification were carried out by Prof.
M.A. Juliano at theDepartment ofBiophysics, FederalUniversity
of Sa˜o Paulo. The amino acid sequences of pep04
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irrelevant peptide (pepIR) (CGSTSAYGC), linear pep04
(AGSYGFNAA) and its specific scrambled peptide (CSFA-
GYNGC) were used to synthesize the peptides as described [26].
Briefly, the synthesis was realized by solid-phase technology
using the 9-fluorenylmethoxy carbonyl strategy. Therefore, all
peptides were obtained with the C-terminal carboxyl group in an
amide form. The resulting peptides were analyzed by reverse-
phase high-performance liquid chromatography (Shimadzu,
Tokyo, Japan). The peptide quality was assessed by a matrix-
assisted laser desorption ionization-time of flight instrument
(Micromass, Manchester, United Kingdom) using a-cyano-4-
hydroxy cinnamic acid as the matrix.2.6. Confocal fluorescence microscopyLabeling for fluorescence microscopy was performed as
described, with modifications [27]. Briefly, P. brasiliensis yeast
cells growing in aerated liquid cultures, in logarithmic phase,
were collected and adjusted to a concentration of 2  106 to
3 106 viable cells/ml. The cells were fixed in cold methanol for
30min in the dark. Thewashed cells (three times with PBS) were
incubatedwith 3%(wt/vol) BSA inPBS (blocking buffer) for 16h
at 4 C. After washing, the cells were incubated in the dark with
either 100 mg/ml of pep04 or pepIR labeled with 6-Carboxy-
fluorescein (6-FAM) for 1 h at room temperature. For confocal
fluorescence microscopy, samples were prepared as described
above. However, in order to better define the fungal surface,
samples were also labeled with monoclonal antibody to P. bra-
siliensisgp75, awell characterized surface protein [13] developed
with Alexa-610 goat anti-Mouse IgG (Invitrogen), and 20 mm
DAPI (40-6-Diamidino-2-phenylindole di-lactate, Invitrogen);
specimens were imaged on a BioRad 1024UV instrument
attached to a ZeissAxiovertmicroscope using a 63 1.4NADIC
oil immersion lens [28]. Z-series were processedwith ImageJ and
renderized with VolumeJ (http://rsb.info.nih.gov/ij/).2.7. Peptides activity on P. brasiliensisThe in vitro antifungal activity of peptides against virulent
or attenuated P. brasiliensis isolates, as demonstrated by
inhibition of CFU after treatment, was measured. Briefly, yeast
cells (virulent or attenuated isolates) were incubated for 24 h
in the presence of peptides (1 mg/ml) in Fava-Netto’s medium.
A final volume of 200 ml was added to each well of 96-wells
plates, at 37 C with shaking, as described [29]. Readings were
performed from day 8e20 and results were expressed in CFU.
The serial concentrations of pep04 and pepIR (1000, 500, 250,
125 and 15.6 mg/ml) were only tested against virulent isolates
of P. brasiliensis.2.8. Blocking infection implantationYeast cells (106) were incubated with 1 mg/ml of pep04,
pepIR, or PBS for 1 h. After that, the viability of fungal
suspensions, determined by trypan blue exclusion in a Neu-
bauer chamber, was always higher than 90%. Then, this fungalsuspension was inoculated i.v. (100 ml of PBS) in the lateral
tail vein of B10.A mice (six animals per group). Control mice
received only PBS. Animals were sacrificed after 3 or 45 days
post-infection, and the number of viable P. brasiliensis cells in
the lungs, spleen and liver were determined by counting CFUs.2.9. Phage treatment of mice infected with P. brasiliensisMice, after anesthesia, were subjected to i.t. P. brasiliensis
infection as described [21]. After 24 h, fd-tet or p04 were
administered i.v. (1011 TU phage/100 ml of PBS) in the lateral
tail vein of BALB/c mice (five animals per group) every day.
Treatment was given for 10 days, 7 days after which they were
sacrificed and the number of viable P. brasiliensis cells in the
lungs were determined by number of CFUs.2.10. Statistical analysisResults were expressed as themean the standard deviations
(SD). Data was analyzed by unpaired Student’s t test with
Welch’s correction (two-tailed) used for comparison of the two
groupswhen the datamet the assumptions of the t tests. Analysis
of variance (ANOVA) followed by the TukeyeKramer test were
sometimes applied (INSTAT software, GraphPad, San Diego,
CA). P values under 0.05 indicated statistical significance.
3. Results3.1. Virulence of P. brasiliensis isolatesThe virulence of P. brasiliensis isolates (virulent and attenu-
ated Pb18) were compared following i.t. administered infection.
After 250 days of infection, virulent Pb18 killed all the animals
and its attenuated counterpart killed a singlemouse out of six. All
animals of the control group (PBS) survived (P < 0.001 relative
to control group) (Fig. 1A). Fig. 1B shows the number of viable
yeast cells recovered from lungs, spleen, and liver of mice after
30, 60 and 90 days post i.t. inoculation. The number of lungCFUs
from virulent Pb18 inoculated mice were significantly higher
than those inoculated with attenuated Pb18. Dissemination of
virulent Pb18 to the spleen and liver was always observed.
Histopathology reflected theCFUdata as shown inFig. 1C andD.
Mice infectedwith attenuatedPb18 showeddiffuse inflammatory
cells in the lungs (Fig. 1C) and a lack of definedgranulomas in the
liver (data not shown) at 30 days post inoculation. Mice infected
with virulent Pb18 showed isolated granulomas after 30 days in
both the lungs (Fig. 1D) and liver (data not shown).3.2. Selection of peptide motifs that bind to the surface
of virulent P. brasiliensis isolatesIn order to begin identification of markers for P. brasiliensis
virulence, the differential expression of ligand molecules on the
surface of the virulent isolate was determined by the use of
phage display technology. As expected, after three selection
rounds were observed enrichment for specific phages to virulent
isolate (data not shown). Six phages presenting repetitions in
Fig. 1. Pb18 isolates displayed clear differences in degree of virulence. (A)
Survival curves of B10.A mice inoculated i.t. with 106 viable yeasts of
different isolates of P. brasiliensis (as indicated), or with PBS (controls). (B)
CFU from lungs, spleen, and liver of mice infected with either virulent or
attenuated Pb18 isolates. Bars depict means  standard errors of log 10 CFU
obtained from groups of 5e6 mice at 30, 60 and 90 days after infection.
(*P < 0.05) and (**P < 0.01) relative to the attenuated isolate. (C and D)
Histopathology (H&E; 100) 30 days after infection, from a representative i.t.
infected mouse with attenuated Pb18. (C) Diffuse inflammatory cells are seen
in the lung. (D) The lung section of mice infected with virulent Pb18 showed
well-organized granulomas (arrow) surrounded by lung preserved areas
(arrowhead).
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considerably enriched, the CGSYGFNAC and CSLERLGFC-
displaying phages, denominated p04 (three repetitions in
second and third rounds) and p06 (seven repetitions in third
round), respectively. However, some phages presented two
repetitions in the third round and were also selected for binding
assays e CYRLTGLWC (p01), CLDSASRGC (p02),
CGLRLESTC (p05), CWLFSVSAC (p03).3.3. Validation of phage binding to yeast cells of a highly
virulent isolate of P. brasiliensisThe degree to which phages bound to virulent or attenuated
Pb18 isolates, compared to control, was analyzed by the
BRASIL method. As expected, binding of the p04, p05 and
p06 phages recovered from virulent Pb18 was significantly
higher when compared to attenuated Pb18 and control in all
experimental conditions tested (P < 0.05) (Fig. 2A). These
phages, with specific binding to virulent isolates, were selected
for further experiments. Binding of the p04 phage to yeast
cells of virulent isolates during independent experiments
(106e1010 TUs) was dose-dependent as compared to control
(Fig. 2B). However, a competitive inhibition assay using
synthetic peptides showed that only pep04 inhibited binding of
its homologous phage. As shown in Fig. 2C, increased
concentration of pep04 decreased the titer of phages recovered
from the virulent isolate, while the inhibition rate of p04
binding increased gradually up to 1 mM or above the pep04
concentration. Pep06 did not inhibit binding of homologous
phage (p06), but unexpectedly, such binding was increased.
Regarding this result, it can only be speculated that some type
of homotypic interaction occurred between the displaying
phage and its derived peptide.3.4. P04 as a possible marker of virulenceTo determine whether p04 phage could be used as a novel
virulence marker, binding assays to six isolates with pre-
defined degrees of virulence were performed. As shown in
Fig. 3, p04 phage showed great binding variability to yeast
cells of different isolates. These results suggest that the fungal
binding molecule is differently expressed by each isolate, as
expected, possibly leading to various degrees of virulence. No
correlation with the original description of each isolate’s
virulence was ever assumed here.3.5. Pep04 binding to the virulent Pb18 isolateYeast cells of virulent or attenuated Pb18 isolates were
incubated with pep04 or pepIR, both coupled to 6-FAM.
PepIR did not bind to either isolate (data not shown). Most of
the attenuated Pb18 cells showed no labeling with pep04-
6FAM (Fig. 4A). Conversely, this labeled peptide was inter-
nalized by the virulent isolate (Fig. 4B and F). Imaging of
sequential optical sections indicated that the labeling was
intracellular and frequently close or overlapping DAPI stain-
ing, as shown in Fig. 4F.3.6. In vitro antifungal activity of peptides selected by
phage displaySince the selected phages bound specifically to the virulent
isolate, we tested if synthetic peptides, derived from these
phages, possessed similar biological activity. Fig. 5A shows
that pep04 (P < 0.01), pep05 (P < 0.01) and pep06 (P < 0.05)
exerted in vitro fungicidal activity against P. brasiliensis and
Fig. 2. Biopanning strategy to isolate phages binding only to highly virulent isolate yeast cells of P. brasiliensis. (A) Cell binding assay with selected phages.
Clones were incubated with highly virulent and attenuated isolates to identify three phages (p04, p05 and p06) presenting higher specificity and affinity to the
former. (B) Binding of the pep04 displaying phage to yeast cells using increasing amounts of phages TU was always higher with the virulent isolate. (C) Inhibition
results between the synthetic peptide (pep04 or pep06) and its homologous phage (p04 or p06); with pep04 concentrations higher than 0.001 mM led to significant
inhibition. [*(P < 0.05) and **(P < 0.01) relative to control, PBS only].
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trations of pep04 were tested and results showed dose
dependence (Fig. 5B). The pep04 and its vehicle (DMSO) did
not show any toxicity to peritoneal macrophages at any of the
concentrations tested during MTT cell viability assays (data
not shown).3.7. The in vitro antifungal activity of pep04 is specific
for virulent isolatesTo confirm the specificity of in vitro pep04 antifungal
activity, additional peptides similar to pep04 were engineered
and synthesized, as described in Material and Methods. As
shown in Fig. 5C, yeast cells of the virulent isolate wereFig. 3. P04 as a biomarker of virulence. Cell binding assays were performed
with p04 and control phage (fd-tet phage, no insert). P04 was incubated with
T10B1 (highly virulent), T4B17 (intermediate virulence), Mg16 (single dental
alveolus lesion, suggesting very low virulence), Pb339 and highly virulent or
attenuated Pb18 isolates. These results suggest that the fungal binding mole-
cule is differently expressed by each isolate, as expected, possibly leading to
various degrees of virulence. *(P < 0.05) and **(P < 0.01) relative to
attenuated isolate Pb18.completely inhibited by pep04. In the same concentration,
none of the other peptides had any effect. These results
suggest a conformational importance to pep04, dependent on
the presence of two cysteines, necessary to form a disulfide
bond and to make the cyclic peptide. This conformation can
permit the correct interaction with the receptor or molecule
important to the fungicidal activity. As shown in Fig. 5D,
when pep04 was incubated with the attenuated isolate, no
fungicidal activity was observed. The fact that the peptide did
not interfere with the proliferation rate of the attenuated isolate
suggests that this peptide is nontoxic and does not recognize
the same, but attenuated, fungus isolate.3.8. Phage p04 prevented the deployment of infectionSince p04 could be utilized to distinguish degrees of viru-
lence by simply binding to molecules of P. brasiliensis, and
pep04 showed in vitro antifungal activity, we decided to
determine if p04 could be employed to influence or block the
development of mycosis. As shown in Fig. 6A, after 3 days,
the number of lung CFUs from mice infected with virulent
Pb18, incubated with p04, were significantly lower than
controls. This result demonstrated that p04 was able to prevent
the implantation of the fungus in the lungs, its primary site of
infection. This difference increased in animals sacrificed 45
days after infection (Fig. 6B). The CFUs recovered from the
lung, spleen, and liver of animals infected with p04 treated
Pb18 were always lower than those from animals treated with
fd-tet. These data suggest that the interaction of the fungus
with p04 inhibits both implantation (Fig. 6A) and deployment
(Fig. 6B) of infection in mice.3.9. Treatment of mice infected with P. brasiliensis with
p04 phageSince p04 prevented the establishment of infection, the next
step was to check whether it was capable of treating mice
already infected with P. brasiliensis. Such mice treated with
p04 showed a significantly reduced CFU average in the lungs
as compared to controls (P < 0.001) (Fig. 6C).
Fig. 4. Pep04 binding to virulent Pb18 isolate. (A) The majority of attenuated Pb18 cells showed no labeling with pep04 coupled to 6-FAM by fluorescence
microscopy. (B) Synthetic peptide (pep04) strongly labeled yeast cells of virulent Pb18 isolate. (CeF) Association of pep04 with DNA in P. brasiliensis yeasts.
Gp75 is a well characterized surface protein (see text). Yeasts were labeled with pep04-6FAM, anti-gp75-Alexa-610 and DAPI and imaged by confocal
microscopy. C: DIC image; D: pep04 renderized image; E: DAPI, renderized image; F: merged pep04 (green), gp75 (red), and DAPI (blue) renderized image.
Arrows point to areas of stronger pep04 labeling; arrowheads indicate stronger DAPI labeling overlapping areas rich in pep04. Bars:10 mm.
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For decades, the virulence of P. brasiliensis has been
a controversial issue because it embodies a great number of
variables [30e33]. Being a characteristic agent that is respon-
sible for a human disease, its definition necessarily bears
a correlation with the disease severity produced by any given
isolate. In humans, however, virulence cannot be measured. In
animal models, virulence varies from the inoculation site to the
animal species used. Furthermore, besides patient’s lungs,
isolates come from a variety of different sources such that the
proper habitat of the fungus is, as yet, unknown [34]. In order to
achieve the goal of identifying a P. brasiliensis virulence
biomarker that would provide for some much needed clarity in
this field of research, the use of a model in which clearly defined
parameters are defined is indispensable. Among these parame-
ters are the use of the same animal, the same inoculation route,
and the same isolate, whose degree of virulence is clear, even if
dependent on artificial procedures such as long times of in vitro
cultivation. We closely followed these parameters and proce-
dures here. None of these considerations, however, restrained
the reporting of several results from different groups that, so far,
left us without the identification of any reliable P. brasiliensis
virulencemarker [30e32,35e37]. The lack of efficient classical
genetic techniques for silencing suspected virulence genes
contributed to this failure. Characterizing such a molecule or its
ligand, for virulent isolate(s), represented the main objective of
this work.
Two variables were taken into account from the beginning
of our studies. Firstly, long cultivation decreases virulence,
a concept that came from Brummer et al. (1990) and Kashino
et al. (1990), and that previously assumed virulence could berecovered by repeated animal passage [18,19], a fact
confirmed by others [38,39]. Secondly, virulence itself is an ill
defined characteristic, as discussed above.
We compared isolate Pb18 with its counterpart that was
maintained in culture for longer than five years and had thus,
lost virulence. The virulent Pb18 isolate not only showed
greater pathogenicity than its non-virulent counterpart, but
also presented striking morphological differences (not shown)
These characteristics could be associated with adaptation of
the fungus in order to survive within the host [30,40,41]. They
also demonstrate that, despite derivation from the same isolate,
these strains are evidently different.
Some Pb proteins and genes have been reported as putative
virulence factors by several authors [33,36,41e43], with no
marker clearly established. To find such a marker or its ligand,
the BRASIL method was employed which involved a peptide
approach for selecting cellular surface motifs based on phage
display libraries [23]. At least one possible virulence marker
for Pb18, the motif CGSYGFNAC, was characterized and
validated. The phage displaying this sequence was named p04
and its homologous synthetic peptide, pep04. Using binding
assays, p04 phage could be utilized for the ranking of various
isolates according to their described level of virulence. Based
on this methodology, we can state that there is a variable
expression of the fungal molecule that binds the peptide.
Nishikaku et al. (2008) evaluated the ability of P. brasiliensis
isolated from armadillos to cause disease in mice. Higher
fungal loads were recovered from mice infected with arma-
dillo isolates as compared with two clinical isolates, suggest-
ing that armadillo isolates were more virulent. One of these
P. brasiliensis isolates, T10B1, was considered even more
virulent than Pb18. Recently, despite decreased virulence due
Fig. 5. The in vitro antifungal activity of selected peptides. (A) Pep04 (P < 0.01), pep05 (P < 0.01) and pep06 (P < 0.05) peptides incubated with yeasts of virulent
Pb18. These peptides demonstrated fungicidal activity in vitro against P. brasiliensis. (B) The fungicidal activity of pep04 in vitro was dose-dependent (P < 0.01)
as compared with pepIR. Bars indicate standard errors. (C) Fungicidal activity of pep04 in vitro against virulent P. brasiliensis isolate depends on molecular
conformation. Pep04L (linear pep04, with cysteine amino acids substituted by alanine), pep04T (scrambled peptide) and pepIR (irrelevant peptide). P < 0.01, as
compared with control (medium only). (D) The fungicidal activity of pep04 against the attenuated isolate showed no killing, thus demonstrating its specificity for
virulent isolates.
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high CFU counts in all the organs [39]. This virulence profile
was also observed by others [17,44]. Canteros et al. (2000)
ranked the isolate Pb339 as slightly virulent and Motta et al.
(2002) as intermediate when compared with virulent Pb18
(after animal passage) [38,45]. In our studies, all isolates,
including Mg16, gave binding results that correlated with their
presumed virulence.
Since p04 could be used to distinguish levels of virulence
by simply binding to molecules of P. brasiliensis, we inves-
tigated whether synthetic peptide pep04 displayed fungicidal
activity in vitro. Similar activity has been demonstrated by
other peptides against Cryptococcus neoformans [46], P.
brasiliensis [29] and Candida albicans [47]. Tested against
both isolates of Pb18, virulent and non-virulent, killingactivity was clearly observed only against the virulent isolate.
The conformational structure of pep04 seemed important since
linear or scrambled peptides did not kill fungi as efficiently.
Our efforts to clarify the mechanisms of fungicidal activity
displayed by pep04 proved unsuccessful. For instance,
confocal experiments showed that this peptide could only be
detected after internalization by yeast. No binding to the
fungal surface was observed. Different experiments designed
to show surface binding were always unsuccessful, suggesting
that peptide entry into the cell is a rapid process. Pep04
showed hydrophobic characteristics and so possibly acts by
distinct mechanisms from those seen with other antimicrobial
peptides (AMP). The general properties of AMP, such as
amphipathicity and cationicity, allow them to form pores in
biological membranes, resulting in microbial death [48].
Fig. 6. P04 inhibits both implantation and deployment of infection in mice. (A) Virulent Pb18 was incubated with p04, p03 (the latter unable to bind to
P. brasiliensis, as shown in Fig. 2) or fd-tet (non inserted) phages for 1 h and then five B10.A mice were infected with each preparation and sacrificed 72 h after the
infection. The number of lung CFUs from virulent Pb18 incubated with p04 were significantly lower than p03, fd-tet phages, or controls (P < 0.01). (B) Virulent
Pb18 was incubated with p04 or fd-tet phages for 1 h after which B10.A mice were infected (5 animals). Sacrificed 45 days after the infection, these mice showed
that the difference in number of lung CFUs became more pronounced (P < 0.01), with no evidence of dissemination. Spleen and liver CFUs were not different. (C)
Mice treated with p04 phage showed significantly reduced CFU in the lungs as compared with controls (Fd-tet e non inserted phage). These results are repre-
sentative of three independent experiments (**P < 0.001).
258 E.S. Kioshima et al. / Microbes and Infection 13 (2011) 251e260Moreover, pep04 displayed a marked association with DAPI
labeling, suggesting that after spontaneously diffusing into the
cytoplasm of fixed or unfixed cells, it might bind to the fungal
DNA or to nuclear proteins with regulatory functions, thus
suggesting a possible mechanism of fungal killing. Though
highly speculative, these possibilities cannot be ruled out.
These findings led us to determine whether similar effects
could be obtained in vivo. Phage p04, when given together
with the fungus, was able to inhibit implantation as well as
dissemination of the disease. To demonstrate how p04 does
this, as we confirmed by repeating the experiment several
times, may be an almost impossible task. No fungus or its
dissemination could be found, making it impracticable to
check whether the agent died, became incapable of multi-
plying, or had some important adhesion molecule blocked.
These results indicate that both p04 and pep04 can be
considered biomarkers of virulence in PCMby binding assays, as
are similarly used nowadays somemonoclonal antibodies.On the
other hand, in vivo assays demonstrated that p04 phage or pep04
could interferewith the pathogenicity of this mycosis. Therefore,
beyond selectively binding to yeast cells of virulentP. brasiliensis
isolates, recognition of a specific virulence marker by p04 phage
and pep04 make plausible the development of an effective ther-
apeutic adjuvant. This task should be pursued by a different
approach since peptides, in the long run, are very unstable.
Although these results are preliminary, the model of selection
based on molecules preferentially expressed in virulent isolates
suggests alternatives to current antifungal therapy.
Specific peptides as those herein described are the first real
biomarkers of virulence. By opening the possibility of char-
acterizing and purifying their target proteins, whose functions
may then be specifically hindered, such peptides can reveal
new approaches for the control of PCM.
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